CAMBRIDGE, Mass. & SALISBURY, England, March 03, 2025--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of novel sebetralstat data related to laryngeal hereditary ...
Shares of KALV stock opened at $11.92 on Friday. The firm’s 50 day moving average price is $9.31 and its 200-day moving average price is $10.31. KalVista Pharmaceuticals has a one year low of $7 ...
$KALV insiders have traded $KALV stock on the open market 18 times in the past 6 months. Of those trades, 6 have been purchases and 12 have been sales. Here’s a ...
$KALV insiders have traded $KALV stock on the open market 20 times in the past 6 months. Of those trades, 8 have been purchases and 12 have been sales. Here’s a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback